Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Evaluation of current diagnostic workup for pediatric severe aplastic anemia: Low incidence of cryptic inherited bone marrow failure syndromes

Blood (2025) 146 (Supplement 1): 1423.

https://doi.org/10.1182/blood-2025-1423

Published: 2025

Journal Articles

Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study

Kirsten Williams, Jennifer Holter-Chakrabarty, Sara Vesely, Marie Gordon, Ashwin Koppayi, Yvonne Suessmuth, Iskra Pusic, John McCarty, Philip McCarthy, Asad Bashey, Gregory Yanik, Michelle Schoettler, Valerie Stewart, Sarita Layton, Stephen Spellman, Wael Saber, Christopher Porter, Lucy Godley

Blood (2025) 146 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2025-4209

Published: 2025

Journal Articles

Multicenter assessment of absolute neutrophil counts (ANC) and white blood cell counts (WBC) in healthy participants with the erythrocyte duffy null phenotype or genotype

Lauren Merz, Gilles Attipoe, Christina Barriteau, Michael Blechner, Eric Burks, Cecelia Calhoun, Sally Campbell Lee, Vivian Chang, Stella Chou, Adam Cuker, Emmanuel Fadeyi, Warren Fingrut, Victoria Forbes, Ivo Francischetti, Vijayakrishna Gadi, Richard Godby, Lucy Godley, Abraham Haimed, Hyojeong Han, Richard Haspel, Chibuzo Ilonze, Cyril Jacquot, Peng Ji, Justin Juskewitch, Matthew Karafin, Kimberly Klein, Nicole Kucine, Priya Kumar, Margarita Kushnir, David Levitz, Michael Lewis, Geling Li, Zhen Mei, Sabrina Racine Brzostek, Gary Rose, Corinna Schultz, Alexa Siddon, Christine Sillings, John Mark Sloan, Amy Soni, Don Stevens, Charlotte Story, James Szymanski, Clifford Takemoto, Alexis Thompson, Rahma Warsame, Angela Weyand, Samuel Wilson, Nibal Zaghloul, Yadashe Belay, Aliza Fink, Patricia Frustace, Jamie Tyson, Nathalie Van Havre, Maureen Okam Achebe

Blood (2025) 146 (Supplement 1): 1074.

https://doi.org/10.1182/blood-2025-1074

Published: 2025

Journal Articles

Modeling germline DDX41 and/or CHEK2 mutations using patient-derived bone marrow Organoids

Inci Aydemir, Xu Han, Honghao Bi, Ermin Li, Kehan Ren, Pan Wang, Laya Soleimani, Madina Sukhanova, Lucy Godley, Peng Ji

Blood (2025) 146 (Supplement 1): 1444.

https://doi.org/10.1182/blood-2025-1444

Published: 2025

Journal Articles

Germline DDX41 Mutations Disrupt Hematopoiesis and Microenvironment in Patient-Derived Bone Marrow Organoids

Inci Aydemir, Xu Han, Honghao Bi, Ermin Li, Kehan Ren, Pan Wang, Madina Sukhanova, Lucy Godley, Peng Ji

Blood (2024) 144 (Supplement 1): 4093.

https://doi.org/10.1182/blood-2024-211026

Published: 2024

Journal Articles

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric AML

Lauren Harmon, Zachary S Hattig, Yizhou Peter Huang, Caliese Beckford, Xiaotu Ma, Rhonda E. Ries, Soheil Meshinchi, Lucy Godley, Timothy J Triche, Jr.

Blood (2024) 144 (Supplement 1): 4092.

https://doi.org/10.1182/blood-2024-210515

Published: 2024

Journal Articles

Pathogenic Germline Variants in the DNA Damage Repair Pathway Are Enriched in Patients with Hematologic Malignancies with Prior Exposure to Cytotoxic Therapies Compared to Patients with Multiple Cancers without Prior Exposure

Devendra Hiwase, Zoe Price, Chung How Kok, Monika Kutyna, Deepak Singhal, Naranie Shanmuganathan, Lesley Rawlings, David M Ross, David T Yeung, Anna Brown, Christopher N. Hahn, Lucy Godley, Caner Saygin, Hamish S Scott

Blood (2024) 144 (Supplement 1): 4596.

https://doi.org/10.1182/blood-2024-211795

Published: 2024

Journal Articles

Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series

Lara Wahlster, Jared H. Rowe, Nina Weichert-Leahey, Robert Grant Rowe, Karyn Brundige, Lucy Godley, Jason Xiaojun Cheng, Michael W Drazer, Christopher R. Reilly, Alan D. Michelson, Alan B. Cantor, Akiko Shimamura, Jacob R. Bledsoe

Blood (2024) 144 (Supplement 1): 5708.

https://doi.org/10.1182/blood-2024-208018

Published: 2024

Journal Articles

CD74 Signaling Regulates Inflammatory Stress to Drive Defective Hematopoiesis and Fitness Advantage of Progenitors in RUNX1-Familial Platelet Disorder

Blood (2024) 144 (Supplement 1): 198.

https://doi.org/10.1182/blood-2024-211542

Published: 2024

Journal Articles

ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy

Blood (2023) 142 (Supplement 2): LBA-6.

https://doi.org/10.1182/blood-2023-191986

Published: 2023

Journal Articles

Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals

Jie Liu, Duc Tran, Irenaeus C.C. Chan, Brian Wiley, Caroline Watson, Armel L. Batchi-Bouyou, Xiaoyu Zong, Konrad H. Stopsack, Paul Pharoah, Li Ding, Jamie R Blundell, Yin Cao, Matthew J. Walter, Nilanjan Chatterjee, Kenneth Offit, Lucy Godley, Daniel C. Link, Zsofia Stadler, Kelly L. Bolton

Blood (2023) 142 (Supplement 1): 811.

https://doi.org/10.1182/blood-2023-182423

Published: 2023

Journal Articles

Interplay between Inflammatory Microenvironment and RUNX1-Mediated Transcriptomic Changes Drives Defective Hematopoiesis in Familial Platelet Disorder

Blood (2023) 142 (Supplement 1): 945.

https://doi.org/10.1182/blood-2023-187750

Published: 2023

Journal Articles

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Blood (2018) 132 (Supplement 1): 5849.

https://doi.org/10.1182/blood-2018-99-118979

Published: 2018

Journal Articles

Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)

Amy Wang, MD MPH, Howard Weiner, Richard A. Larson, MD, Olatoyosi Odenike, MD, Andrew S Artz, MD, Michael R. Bishop, MD, Lucy Godley, MD PhD, Michael Thirman, MD, Satyajit Kosuri, MD, Jane Churpek, MD, Emily K Curran, MD, Kristen Pettit, MD, Wendy Stock, MD, Hongtao Liu, MD PhD

Blood (2018) 132 (Supplement 1): 4073.

https://doi.org/10.1182/blood-2018-99-120244

Published: 2018

Journal Articles

Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB

Anna L. Brown, PhD BSc, Mark Armstrong, MSc, David Lawrence, Paul Wang, Peer Arts, PhD, Nicolas Duployez, PharmD, PhD, Jane Churpek, MD, Kiran Tawana, MD, Erin Degelman, MSc, BSc, Georges Natsoulis, PhD, Monica L. Guzman, PhD, Mrinal M. Patnaik, MD MBBS, Akiko Shimamura, MD PhD, Alan B. Cantor, MD PhD, Tim Ripperger, MD PhD, Brigitte Schlegelberger, MD PhD, Doris Steinemann, PhD, Courtney D. DiNardo, MD MSc, Cristina Mecucci, MD PhD, Elvira DRP Velloso, MD PhD, Fabio PS Santos, MD, Marcela CA Silva, Uma Borate, MD, Shannon K. McWeeney, PhD, Grzegorz Nalepa, MD PhD, Susanne Ragg, MD PhD, Erika Mijin Kwon, PhD, Anupriya Agarwal, PhD, Stephen Langabeer, PhD, Jeffery M. Klco, MD PhD, Jun J. Yang, PhD, Cecily Forsyth, FRACP, FRCPA, MBBS, Sally Mapp, MD PhD, Helen Mar Fan, MD, Lesley Rawlings, PhD, Rachel Susman, Sue Morgan, FRACP, FRCPA, MBBS, Andrew H Wei, MBBS,PhD, Inderjeet Dokal, MD, Tom Vulliamy, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Deepak Singhal, MBBS, MD FRACP, FRCPA, Susan Branford, PhD, Elli Papaemmanuil, PhD, Jean Soulier, MDPhD, Stefan Fröhling, MD, Alwin Kramer, MD, Guy Sauvageau, MD PhD, Neil Morgan, Carolyn Owen, Csaba Bödör, PhD, Jude Fitzgibbon, Hugh Y. Rienhoff, Jr., MD, Mineo Kurokawa, MD PhD, Lucy Godley, MD PhD, Claude Preudhomme, Paul P Liu, MD PhD, Nicola Poplawski, MD, Christopher N. Hahn, PhD, Hamish S. Scott, PhD

Blood (2018) 132 (Supplement 1): 5241.

https://doi.org/10.1182/blood-2018-99-118017

Published: 2018

Journal Articles

Dose Escalation Prophylactic Donor Lymphocyte Infusion (pDLI) after T-Cell Depleted (TCD) Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Is Feasible and Results in Higher Donor Chimerism, Faster Immune Re-Constitution and Prolonged PFS

Kothari Shawn, MD, Andrew Artz, MD, Sang Mee Lee, PhD, Noreen Fulton, BS, Jae-Hyun Park, Wendy Stock, MD, Richard A. Larson, MD, Olatoyosi Odenike, MD, Justin Kline, MD, Lucy Godley, MD PhD, James LaBelle, MD PhD, Satyajit Kosuri, MD, Peter A Riedell, MD, Yusuke Nakamura, MD, Michael R. Bishop, MD, Hongtao Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4572.

https://doi.org/10.1182/blood.V130.Suppl_1.4572.4572

Published: 2017

Journal Articles

Validation of Pre-Transplant Biomarker Measurement and Risk Score for Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant (HCT)

Michael J. Leukam, MD, Lucy Godley, MD PhD, Justin Kline, MD, Richard A. Larson, MD, Hongtao Liu, MD PhD, Olatoyosi Odenike, MD, Wendy Stock, MD, Michael R. Bishop, MD, Andrew Artz, MD

Blood (2017) 130 (Supplement 1): 4558.

https://doi.org/10.1182/blood.V130.Suppl_1.4558.4558

Published: 2017

Journal Articles

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

Hongtao Liu, Elizabeth S. Rich, Lucy Godley, Olatoyosi Odenike, Loren Joseph, Susana Marino, Justin Kline, Vu Nguyen, John Cunningham, Richard A. Larson, Paula del Cerro, Linda Schroeder, Lisa Pape, Wendy Stock, Amittha Wickrema, Andrew S. Artz, Koen van Besien

Blood (2011) 118 (24): 6438–6445.

https://doi.org/10.1182/blood-2011-08-372508

Published: 2011

Includes: Supplemental data

Journal Articles

Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation: Final Report of a Phase I-II Study

Koen M. Van Besien, MD, Wendy Stock, MD, Elizabeth Shima Rich, MD, PhD, Olatoyosi Odenike, MD, Lucy Godley, MD, PhD, Peter O'Donnell, MD, Justin Kline, MD, Vu H. Nguyen, MD, Paula Del Cerro, RN, Richard A. Larson, MD, Andrew Artz, MD MS

Blood (2011) 118 (21): 1948.

https://doi.org/10.1182/blood.V118.21.1948.1948

Published: 2011

Journal Articles

Randomized Open-Label Phase II Study of Decitabine in Patients with Low- or Intermediate-1 Risk Myelodysplastic Syndromes,

Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Stefan Faderl, MD, Zeev Estrov, Lucy Godley, MD, PhD, Nashat Y. Gabrail, MD, Jesus G. Berdeja, MD, Ahmed Nadeem, MD, Karen Stein, MD, MPH, Yvonne Noble, RN, BS, Laurent Kassalow, MS, Hagop M. Kantarjian, MD

Blood (2011) 118 (21): 3812.

https://doi.org/10.1182/blood.V118.21.3812.3812

Published: 2011

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Evaluation of current diagnostic workup for pediatric severe aplastic anemia: Low incidence of cryptic inherited bone marrow failure syndromes

Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study

Multicenter assessment of absolute neutrophil counts (ANC) and white blood cell counts (WBC) in healthy participants with the erythrocyte duffy null phenotype or genotype

Modeling germline DDX41 and/or CHEK2 mutations using patient-derived bone marrow Organoids

Germline DDX41 Mutations Disrupt Hematopoiesis and Microenvironment in Patient-Derived Bone Marrow Organoids

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric AML

Pathogenic Germline Variants in the DNA Damage Repair Pathway Are Enriched in Patients with Hematologic Malignancies with Prior Exposure to Cytotoxic Therapies Compared to Patients with Multiple Cancers without Prior Exposure

Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series

CD74 Signaling Regulates Inflammatory Stress to Drive Defective Hematopoiesis and Fitness Advantage of Progenitors in RUNX1-Familial Platelet Disorder

ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy

Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals

Interplay between Inflammatory Microenvironment and RUNX1-Mediated Transcriptomic Changes Drives Defective Hematopoiesis in Familial Platelet Disorder

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)

Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB

Dose Escalation Prophylactic Donor Lymphocyte Infusion (pDLI) after T-Cell Depleted (TCD) Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Is Feasible and Results in Higher Donor Chimerism, Faster Immune Re-Constitution and Prolonged PFS

Validation of Pre-Transplant Biomarker Measurement and Risk Score for Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant (HCT)

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation: Final Report of a Phase I-II Study

Randomized Open-Label Phase II Study of Decitabine in Patients with Low- or Intermediate-1 Risk Myelodysplastic Syndromes,

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only